首页 > 最新文献

Clinical Medicine & Research最新文献

英文 中文
Anthropometric Measures for the Prognosis of Obstructive Sleep Apnea in Obese. 用于预测肥胖症患者阻塞性睡眠呼吸暂停的人体测量指标。
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-08-26 DOI: 10.3121/cmr.2022.1679
Laura Souza Lagares, Ramon Souza Lino, Eric Simas Bomfim, Felipe Almeida Santos, Ciro Oliveira Queiroz, Lélia Lessa Pinto, Luiz Alberto Bastos Almeida, Clarcson Plácido Santos

Objective: The objective of this study was to identify, among the different anthropometric indicators, the one that shows higher discriminatory power for the prognosis of Obstructive Sleep Apnea Syndrome (OSAS).

Design: Observational cross-sectional study PARTICIPANTS: Obese individuals elective to bariatric surgery METHODS: A study based on data of 758 patients aged ≥ 21 years old, of both sexes, in the pre-operatory stage of the surgical procedure of gastric bypass. Obstructive sleep apnea and obstructive sleep hypopnea were evaluated and classified through the apnea-hypopnea index, which was obtained through the examination of polysomnography. Variables were divided into two groups: individuals with and without OSAS. As predictors, measures of body mass index (BMI), neck circumference (NC), and waist circumference (WC) were used.

Results: The area under the ROC curve was used to check the sensitivity and specificity. All evaluated anthropometric indicators showed statistical significance. WC: area of 0.62 (CI 95%: 0.58 - 0.67), NC: area of 0,68 (CI 95%: 0.64 - 0.72) and BMI: area of 0.58 (CI 95%: 0.54 - 0.63).

Conclusion: The investigated anthropometric indicators performed as good predictors of OSAS. However, NC seems to be the best anthropometric indicator for the prognosis of OSAS in obese individuals when compared to BMI and WC.

研究目的本研究的目的是在不同的人体测量指标中,找出对阻塞性睡眠呼吸暂停综合征(OSAS)的预后具有较高鉴别力的指标:设计:观察性横断面研究 参与者:选择减肥的肥胖者方法:一项基于 758 名年龄≥ 21 岁、处于胃旁路手术术前阶段的男女患者数据的研究。通过多导睡眠图检查获得的呼吸暂停-低通气指数,对阻塞性睡眠呼吸暂停和阻塞性睡眠低通气进行评估和分类。变量分为两组:有 OSAS 和无 OSAS 的个体。作为预测指标,使用了体重指数(BMI)、颈围(NC)和腰围(WC)的测量值:结果:采用 ROC 曲线下面积来检测灵敏度和特异性。所有评估的人体测量指标均具有统计学意义。WC: 面积为 0.62 (CI 95%: 0.58 - 0.67),NC: 面积为 0.68 (CI 95%: 0.64 - 0.72),BMI: 面积为 0.58 (CI 95%: 0.54 - 0.63):结论:所研究的人体测量指标都能很好地预测 OSAS。结论:所调查的人体测量指标都能很好地预测 OSAS,但与 BMI 和 WC 相比,NC 似乎是预测肥胖者 OSAS 的最佳人体测量指标。
{"title":"Anthropometric Measures for the Prognosis of Obstructive Sleep Apnea in Obese.","authors":"Laura Souza Lagares, Ramon Souza Lino, Eric Simas Bomfim, Felipe Almeida Santos, Ciro Oliveira Queiroz, Lélia Lessa Pinto, Luiz Alberto Bastos Almeida, Clarcson Plácido Santos","doi":"10.3121/cmr.2022.1679","DOIUrl":"10.3121/cmr.2022.1679","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study was to identify, among the different anthropometric indicators, the one that shows higher discriminatory power for the prognosis of Obstructive Sleep Apnea Syndrome (OSAS).</p><p><strong>Design: </strong>Observational cross-sectional study PARTICIPANTS: Obese individuals elective to bariatric surgery METHODS: A study based on data of 758 patients aged ≥ 21 years old, of both sexes, in the pre-operatory stage of the surgical procedure of gastric bypass. Obstructive sleep apnea and obstructive sleep hypopnea were evaluated and classified through the apnea-hypopnea index, which was obtained through the examination of polysomnography. Variables were divided into two groups: individuals with and without OSAS. As predictors, measures of body mass index (BMI), neck circumference (NC), and waist circumference (WC) were used.</p><p><strong>Results: </strong>The area under the ROC curve was used to check the sensitivity and specificity. All evaluated anthropometric indicators showed statistical significance. WC: area of 0.62 (CI 95%: 0.58 - 0.67), NC: area of 0,68 (CI 95%: 0.64 - 0.72) and BMI: area of 0.58 (CI 95%: 0.54 - 0.63).</p><p><strong>Conclusion: </strong>The investigated anthropometric indicators performed as good predictors of OSAS. However, NC seems to be the best anthropometric indicator for the prognosis of OSAS in obese individuals when compared to BMI and WC.</p>","PeriodicalId":47429,"journal":{"name":"Clinical Medicine & Research","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2022-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544195/pdf/0200147.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10460080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extended Tourniquet Times and the Impact on Wound Healing in Foot Surgery 延长止血带次数及对足部手术伤口愈合的影响
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-08-26 DOI: 10.3121/cmr.2022/1668
Callum Robertson, V. Wilson, R. Meek, R. Carter
Objective: The aim of this study was to compare the effect of tourniquet time less than or in excess of 120 minutes on foot surgery wound healing. Null hypothesis: A tourniquet time of over 120 minutes will not affect wound healing in foot surgery. Design, Setting, Participants and Method: A retrospective comparative cohort analysis was performed on 96 patients undergoing complex hindfoot surgery in a large central teaching hospital. Fifty-five patients receiving tourniquet pressure for >120 minutes and 41 receiving <120 minutes of tourniquet pressure were identified from electronic case records. The primary outcome was surgical wound healing. Secondary outcomes were discharge date and complication rate. Results: There was no significant difference in reported time for wounds to heal in the <120-minute or >120-minute cohort. There were no other significant differences in secondary clinical outcomes and no significant variations in patient demographics. Conclusion: This study suggests that tourniquet times from 2 to 3 hours in foot and ankle surgery with pressures up to 300 mmHg are not associated with a significant effect on wound healing.
目的:本研究的目的是比较止血带时间少于或超过120分钟对足部手术伤口愈合的影响。零假设:在足部手术中,止血带时间超过120分钟不会影响伤口愈合。设计、环境、参与者与方法:对某大型中心教学医院96例复杂后足手术患者进行回顾性比较队列分析。55例患者接受止血带压血120分钟,41例接受120分钟队列治疗。在次要临床结果方面没有其他显著差异,在患者人口统计学方面也没有显著差异。结论:本研究表明,在压力高达300 mmHg的足部和踝关节手术中,止血带时间为2至3小时对伤口愈合没有显著影响。
{"title":"Extended Tourniquet Times and the Impact on Wound Healing in Foot Surgery","authors":"Callum Robertson, V. Wilson, R. Meek, R. Carter","doi":"10.3121/cmr.2022/1668","DOIUrl":"https://doi.org/10.3121/cmr.2022/1668","url":null,"abstract":"Objective: The aim of this study was to compare the effect of tourniquet time less than or in excess of 120 minutes on foot surgery wound healing. Null hypothesis: A tourniquet time of over 120 minutes will not affect wound healing in foot surgery. Design, Setting, Participants and Method: A retrospective comparative cohort analysis was performed on 96 patients undergoing complex hindfoot surgery in a large central teaching hospital. Fifty-five patients receiving tourniquet pressure for >120 minutes and 41 receiving <120 minutes of tourniquet pressure were identified from electronic case records. The primary outcome was surgical wound healing. Secondary outcomes were discharge date and complication rate. Results: There was no significant difference in reported time for wounds to heal in the <120-minute or >120-minute cohort. There were no other significant differences in secondary clinical outcomes and no significant variations in patient demographics. Conclusion: This study suggests that tourniquet times from 2 to 3 hours in foot and ankle surgery with pressures up to 300 mmHg are not associated with a significant effect on wound healing.","PeriodicalId":47429,"journal":{"name":"Clinical Medicine & Research","volume":"62 1","pages":"141 - 146"},"PeriodicalIF":1.4,"publicationDate":"2022-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88353309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meperidine-Ketorolac Combination Provides Better Analgesia than Meperidine Alone in Postoperative Patients. 甲哌啶-酮咯酸复方制剂为术后患者提供的镇痛效果优于单用甲哌啶。
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-08-23 DOI: 10.3121/cmr.2022.1628
Nelly N Umukoro, Shola S Jamgbadi, Erdoo S Isamade

Background: Our study objective was to assess if multi-modal analgesia with meperidine-ketorolac combination provides superior analgesia or reduces opioid requirement following surgery compared to Meperidine alone.

Design: Double-blind randomized controlled trial.

Setting: Postoperative pain control in orthopedic ward after spinal anesthesia.

Patients: American Society of Anesthesiology (ASA) risk I or II (ASA I/II) patients who had lower limb implant surgery (88) at our center from September 2014 to July 2015.

Interventions: Patients were randomly assigned to receive either 1 mg/kg of intravenous (IV) meperidine and 30 mg of IV ketorolac (treatment group) or 1 mg/kg of IV meperidine (control group) post-surgery, administered every hour for the first 6 hours during the first 24 hours post-surgery. In addition, patients received intravenous meperidine on an 'as needed basis' during the first 24 hours of the postoperative period.

Measurements: Outcomes were time-to-first analgesia request postoperatively; cumulative opioid dose in first 24 hours post-surgery; frequency of side effects; and patient satisfaction with pain relief using a Likert scale. Numerical rating scale (NRS) pain scores hourly for the first 6 hours, then the 8th, 12th, 16th, 18th and 24th hour post-surgery were assessed.

Results: There was a significant delay in time of first request for analgesia (460 min vs 225 min; P=0.03) and a reduction in opioid consumption in 24 hours (299 mg vs 325 mg; P=0.01) in the meperidine/ketorolac group compared with the meperidine alone group which were both statistically significant. Patient satisfaction with pain relief was better in the treatment group (P=0.01). Additionally, there were fewer side effects in the treatment group than in the control group but this was not statistically significant.

Conclusions: Adding ketorolac to meperidine reduced postoperative pain, reduced patient daily opioid requirement, increased patient satisfaction with pain relief, without increasing the frequency of side effects. Therefore, IV ketorolac addition to opioids may be a reasonable option in multimodal analgesic protocol.

研究背景我们的研究目的是评估与单独使用甲哌啶相比,使用甲哌啶-酮咯酸组合的多模式镇痛是否能提供更好的镇痛效果或减少术后对阿片类药物的需求:双盲随机对照试验:背景:骨科病房脊髓麻醉后的术后疼痛控制:美国麻醉学会(ASA)风险I级或II级(ASA I/II)患者,2014年9月至2015年7月在本中心进行下肢植入手术(88例):随机分配患者在术后接受1 mg/kg 静脉注射(IV)甲哌啶和30 mg IV酮咯酸(治疗组)或1 mg/kg IV甲哌啶(对照组),在术后24小时内的前6小时每小时给药一次。此外,在术后的头 24 小时内,患者还可根据 "需要 "静脉注射甲哌立定:结果:术后首次要求镇痛的时间;术后头 24 小时内阿片类药物的累积剂量;副作用发生频率;以及患者对疼痛缓解的满意度(采用李克特量表)。在术后最初 6 小时,然后在术后第 8、12、16、18 和 24 小时,每小时对数字评分法(NRS)疼痛评分进行评估:结果:与单独使用甲哌啶组相比,甲哌啶/酮咯酸组首次要求镇痛的时间明显推迟(460 分钟 vs 225 分钟;P=0.03),24 小时内阿片类药物的用量明显减少(299 毫克 vs 325 毫克;P=0.01),这两项数据均有统计学意义。治疗组患者对疼痛缓解的满意度更高(P=0.01)。此外,治疗组的副作用少于对照组,但无统计学意义:在甲哌啶基础上加用酮咯酸可减轻术后疼痛,减少患者每日阿片类药物的需求量,提高患者对疼痛缓解的满意度,但不会增加副作用的发生频率。因此,在阿片类药物中添加静脉注射酮咯酸可能是多模式镇痛方案中的一个合理选择。
{"title":"Meperidine-Ketorolac Combination Provides Better Analgesia than Meperidine Alone in Postoperative Patients.","authors":"Nelly N Umukoro, Shola S Jamgbadi, Erdoo S Isamade","doi":"10.3121/cmr.2022.1628","DOIUrl":"10.3121/cmr.2022.1628","url":null,"abstract":"<p><strong>Background: </strong>Our study objective was to assess if multi-modal analgesia with meperidine-ketorolac combination provides superior analgesia or reduces opioid requirement following surgery compared to Meperidine alone.</p><p><strong>Design: </strong>Double-blind randomized controlled trial.</p><p><strong>Setting: </strong>Postoperative pain control in orthopedic ward after spinal anesthesia.</p><p><strong>Patients: </strong>American Society of Anesthesiology (ASA) risk I or II (ASA I/II) patients who had lower limb implant surgery (88) at our center from September 2014 to July 2015.</p><p><strong>Interventions: </strong>Patients were randomly assigned to receive either 1 mg/kg of intravenous (IV) meperidine and 30 mg of IV ketorolac (treatment group) or 1 mg/kg of IV meperidine (control group) post-surgery, administered every hour for the first 6 hours during the first 24 hours post-surgery. In addition, patients received intravenous meperidine on an 'as needed basis' during the first 24 hours of the postoperative period.</p><p><strong>Measurements: </strong>Outcomes were time-to-first analgesia request postoperatively; cumulative opioid dose in first 24 hours post-surgery; frequency of side effects; and patient satisfaction with pain relief using a Likert scale. Numerical rating scale (NRS) pain scores hourly for the first 6 hours, then the 8th, 12th, 16th, 18th and 24th hour post-surgery were assessed.</p><p><strong>Results: </strong>There was a significant delay in time of first request for analgesia (460 min vs 225 min; <i>P</i>=0.03) and a reduction in opioid consumption in 24 hours (299 mg vs 325 mg; <i>P</i>=0.01) in the meperidine/ketorolac group compared with the meperidine alone group which were both statistically significant. Patient satisfaction with pain relief was better in the treatment group (<i>P</i>=0.01). Additionally, there were fewer side effects in the treatment group than in the control group but this was not statistically significant.</p><p><strong>Conclusions: </strong>Adding ketorolac to meperidine reduced postoperative pain, reduced patient daily opioid requirement, increased patient satisfaction with pain relief, without increasing the frequency of side effects. Therefore, IV ketorolac addition to opioids may be a reasonable option in multimodal analgesic protocol.</p>","PeriodicalId":47429,"journal":{"name":"Clinical Medicine & Research","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2022-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544193/pdf/0200133.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10455929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effectiveness of Oral Immunotherapy in Patients with Sesame Anaphylaxis using Omalizumab. 使用奥马珠单抗对芝麻过敏性休克患者进行口服免疫疗法的效果。
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-08-23 DOI: 10.3121/cmr.2022.1730
Fereshteh Salari, Mohammad Hassan Bemanian, Morteza Fallahpour, Seyed Alireza Mahdaviani, Sima Shokri, Majid Khoshmirsafa, Farhad Seif, Mohammad Nabavi, Saba Arshi

Objective: Sesame allergy is the most prevalent allergy to seeds. Oral immunotherapy (OIT) is defined as continuous consumption of an allergen at special doses and time. Omalizumab (Anti-IgE) increases tolerance to allergens used in OIT. This study evaluated the effectiveness of a new sesame OIT protocol in patients with sesame anaphylaxis in combination with omalizumab.

Methods: In this prospective open-label interventional trial study, 11 patients with a history of sesame anaphylaxis were enrolled after confirmation by oral food challenge (OFC) test. At baseline, skin prick test (SPT) and skin prick to prick (SPP) test were performed. Serum sesame-specific IgE (sIgE) levels were measured. The maintenance phase was continued at home with daily sesame intake for 4 months. At the end of month 4, the OFC and above-mentioned tests were repeated to evaluate the treatment effectiveness.

Results: All 11 patients who underwent sesame OIT after 4 months could tolerate a dietary challenge of 22 ml tahini (natural sesame seed, equal to 5,000 mg of sesame protein and higher) and the average of wheal diameter in the SPT and SPP tests significantly decreased after desensitization.

Conclusion: This OIT protocol may be a promising desensitization strategy for patients with sesame anaphylaxis. Also, omalizumab appears to have reduced the severity of reactions.

目的:芝麻过敏是最常见的种子过敏。口服免疫疗法(OIT)是指以特殊剂量和时间持续服用过敏原。奥马珠单抗(Anti-IgE)可增强对口服免疫疗法中使用的过敏原的耐受性。本研究评估了芝麻过敏性休克患者使用新的芝麻 OIT 方案和奥马珠单抗的效果:在这项前瞻性开放标签干预试验研究中,11 名有芝麻过敏性休克病史的患者经口服食物挑战(OFC)试验确认后被纳入研究。基线时,进行皮肤点刺试验(SPT)和皮肤点刺对点刺试验(SPP)。测量血清芝麻特异性 IgE(sIgE)水平。维持阶段为 4 个月,每天在家摄入芝麻。第4个月结束时,再次进行OFC和上述测试,以评估治疗效果:结果:4 个月后接受芝麻 OIT 的 11 名患者均能耐受 22 毫升芝麻酱(天然芝麻,相当于 5,000 毫克芝麻蛋白及更高)的饮食挑战,脱敏后 SPT 和 SPP 测试中的乳清直径平均值显著下降:结论:对于芝麻过敏性休克患者来说,这种 OIT 方案可能是一种很有前景的脱敏策略。结论:对于芝麻过敏性休克患者来说,这种 OIT 方案可能是一种很有前景的脱敏策略,而且奥马珠单抗似乎也能减轻反应的严重程度。
{"title":"The Effectiveness of Oral Immunotherapy in Patients with Sesame Anaphylaxis using Omalizumab.","authors":"Fereshteh Salari, Mohammad Hassan Bemanian, Morteza Fallahpour, Seyed Alireza Mahdaviani, Sima Shokri, Majid Khoshmirsafa, Farhad Seif, Mohammad Nabavi, Saba Arshi","doi":"10.3121/cmr.2022.1730","DOIUrl":"10.3121/cmr.2022.1730","url":null,"abstract":"<p><strong>Objective: </strong>Sesame allergy is the most prevalent allergy to seeds. Oral immunotherapy (OIT) is defined as continuous consumption of an allergen at special doses and time. Omalizumab (Anti-IgE) increases tolerance to allergens used in OIT. This study evaluated the effectiveness of a new sesame OIT protocol in patients with sesame anaphylaxis in combination with omalizumab.</p><p><strong>Methods: </strong>In this prospective open-label interventional trial study, 11 patients with a history of sesame anaphylaxis were enrolled after confirmation by oral food challenge (OFC) test. At baseline, skin prick test (SPT) and skin prick to prick (SPP) test were performed. Serum sesame-specific IgE (sIgE) levels were measured. The maintenance phase was continued at home with daily sesame intake for 4 months. At the end of month 4, the OFC and above-mentioned tests were repeated to evaluate the treatment effectiveness.</p><p><strong>Results: </strong>All 11 patients who underwent sesame OIT after 4 months could tolerate a dietary challenge of 22 ml tahini (natural sesame seed, equal to 5,000 mg of sesame protein and higher) and the average of wheal diameter in the SPT and SPP tests significantly decreased after desensitization.</p><p><strong>Conclusion: </strong>This OIT protocol may be a promising desensitization strategy for patients with sesame anaphylaxis. Also, omalizumab appears to have reduced the severity of reactions.</p>","PeriodicalId":47429,"journal":{"name":"Clinical Medicine & Research","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2022-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544196/pdf/0200125.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10455931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cinema's Terrifying Realities: Pandemics, Zombification, and SARS-COV-2. 电影中的恐怖现实:大流行病、僵尸化和 SARS-COV-2
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-08-23 DOI: 10.3121/cmr.2022.1742
Dennis Henkel, Eelco F M Wijdicks

Contagion is a function of the properties of the pathogen, social interactions, and personal relationships in the society it attacks. Filmmakers in the horror genre were inspired by the idea of rabies as a virus that could mutate into something more dangerous. Fictional epidemics of scavenging undead were often attributed to encephalitis caused by rabies or a mutated rabies virus. During the early months of the SARS-COV-2 pandemic, there was a spike in streaming of Contagion that portrays a viral infectious disease modeled after a bat virus that spreads at an alarming rate, unleashing a global public panic and a clueless governmental response. We wanted to trace how filmmakers used rabies pathology as source material for their plots. We searched internet film databases and reviewed fictional films that utilized this plot device. Many dystopic, rabies-induced pandemic scenarios - mostly from the zombie genre - reveal parallels to the COVID-19 pandemic. Many zombie films, despite their absurd premise, anticipated the realities of future pandemics.

传染是病原体的特性、社会互动以及它所攻击的社会中的人际关系的一个函数。狂犬病是一种病毒,可以变异成更危险的东西。小说中出现的拾荒亡灵流行病往往被归因于狂犬病或变异狂犬病病毒引起的脑炎。在 SARS-COV-2 大流行的最初几个月,《传染病》的播放量激增,该片描述了一种以蝙蝠病毒为原型的病毒性传染病,以惊人的速度传播,引发了全球公众的恐慌和政府的无知反应。我们希望追踪电影制片人如何利用狂犬病病理学作为情节的素材。我们搜索了互联网电影数据库,并查阅了利用这一情节设置的虚构电影。许多由狂犬病引发的末世大流行场景--大多来自僵尸题材--都揭示了与 COVID-19 大流行的相似之处。许多僵尸电影尽管前提荒诞不经,但却预见到了未来大流行病的现实。
{"title":"Cinema's Terrifying Realities: Pandemics, Zombification, and SARS-COV-2.","authors":"Dennis Henkel, Eelco F M Wijdicks","doi":"10.3121/cmr.2022.1742","DOIUrl":"10.3121/cmr.2022.1742","url":null,"abstract":"<p><p>Contagion is a function of the properties of the pathogen, social interactions, and personal relationships in the society it attacks. Filmmakers in the horror genre were inspired by the idea of rabies as a virus that could mutate into something more dangerous. Fictional epidemics of scavenging undead were often attributed to encephalitis caused by rabies or a mutated rabies virus. During the early months of the SARS-COV-2 pandemic, there was a spike in streaming of <i>Contagion</i> that portrays a viral infectious disease modeled after a bat virus that spreads at an alarming rate, unleashing a global public panic and a clueless governmental response. We wanted to trace how filmmakers used rabies pathology as source material for their plots. We searched internet film databases and reviewed fictional films that utilized this plot device. Many dystopic, rabies-induced pandemic scenarios - mostly from the zombie genre - reveal parallels to the COVID-19 pandemic. Many zombie films, despite their absurd premise, anticipated the realities of future pandemics.</p>","PeriodicalId":47429,"journal":{"name":"Clinical Medicine & Research","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2022-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544194/pdf/0200121.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10455930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of Vasoconstrictor-Induced Non-Occlusive Mesenteric Ischemia of Colon: A Systematic Review. 血管收缩剂诱发结肠非闭塞性肠系膜缺血的结果:系统回顾
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-06-08 DOI: 10.3121/cmr.2022.1726
Umer Farooq, Daniel Alcantar, Zahoor Ahmed, Ayokunle T Abegunde

Background: Nonocclusive mesenteric ischemia (NOMI) is due to mesenteric arterial hypoperfusion from several causes, such as hypovolemia, heart failure, shock, vasoconstrictors, and severe liver or renal disease. Vasoconstrictor-induced NOMI is usually iatrogenic or associated with cocaine use.

Objectives: Anecdotal reports suggest that cocaine-induced NOMI has the highest mortality among vasoconstrictors. This review aims to compare the outcomes of colonic NOMI secondary to cocaine versus other vasoconstrictors.

Methods: We conducted a systematic search of MEDLINE from inception through October 2016 to find articles on colonic NOMI. The study's primary outcomes were mortality and hospital length of stay (LOS), while secondary outcomes included the need for surgery. We reported descriptive statistics as percentages or median and interquartile range (IQR). We compared continuous data with the Mann-Whitney test and categorical data with Fisher's exact test; P < 0.05 was statistically significant.

Results: Of the 59 studies, 20 case reports and 3 case series (n= 27 patients) met the inclusion criteria. There was no difference in mortality between cocaine-induced NOMI and non-cocaine NOMI (P=1.0). There were statistically significant differences between cocaine and non-cocaine vasoconstrictor-induced colonic NOMI regarding surgery (60% vs. 5.8%, P=0.03) and median LOS (7 days vs. 4 days, P=0.04).

Conclusion: Cocaine-induced NOMI and non-cocaine NOMI both appear to have a relatively high but similar mortality rate, but the former is associated with increased requirement for surgery and LOS; prompt recognition of this clinical entity is required to improve outcomes.

背景:非闭塞性肠系膜缺血(NOMI)是由多种原因造成的肠系膜动脉灌注不足引起的,如低血容量、心力衰竭、休克、血管收缩剂以及严重的肝脏或肾脏疾病。血管收缩剂诱发的 NOMI 通常是先天性的,或与使用可卡因有关:轶事报道表明,在血管收缩剂中,可卡因诱发的 NOMI 死亡率最高。本综述旨在比较继发于可卡因和其他血管收缩剂的结肠 NOMI 的结果:我们对 MEDLINE 进行了系统性检索,从开始到 2016 年 10 月,寻找有关结肠 NOMI 的文章。研究的主要结果是死亡率和住院时间(LOS),次要结果包括手术需求。我们以百分比或中位数和四分位数间距 (IQR) 的形式报告了描述性统计数据。我们用 Mann-Whitney 检验比较连续数据,用 Fisher's 精确检验比较分类数据;P < 0.05 为有统计学意义:在 59 项研究中,20 项病例报告和 3 项系列病例(n= 27 名患者)符合纳入标准。可卡因诱发的NOMI与非可卡因诱发的NOMI在死亡率上没有差异(P=1.0)。可卡因和非可卡因血管收缩剂诱发的结肠NOMI在手术(60% vs. 5.8%,P=0.03)和中位LOS(7天 vs. 4天,P=0.04)方面存在统计学差异:结论:可卡因诱导的结肠NOMI和非可卡因诱导的结肠NOMI的死亡率相对较高,但两者相似,但前者与手术需求和住院时间增加有关;需要及时识别这一临床实体以改善预后。
{"title":"Outcomes of Vasoconstrictor-Induced Non-Occlusive Mesenteric Ischemia of Colon: A Systematic Review.","authors":"Umer Farooq, Daniel Alcantar, Zahoor Ahmed, Ayokunle T Abegunde","doi":"10.3121/cmr.2022.1726","DOIUrl":"10.3121/cmr.2022.1726","url":null,"abstract":"<p><strong>Background: </strong>Nonocclusive mesenteric ischemia (NOMI) is due to mesenteric arterial hypoperfusion from several causes, such as hypovolemia, heart failure, shock, vasoconstrictors, and severe liver or renal disease. Vasoconstrictor-induced NOMI is usually iatrogenic or associated with cocaine use.</p><p><strong>Objectives: </strong>Anecdotal reports suggest that cocaine-induced NOMI has the highest mortality among vasoconstrictors. This review aims to compare the outcomes of colonic NOMI secondary to cocaine versus other vasoconstrictors.</p><p><strong>Methods: </strong>We conducted a systematic search of MEDLINE from inception through October 2016 to find articles on colonic NOMI. The study's primary outcomes were mortality and hospital length of stay (LOS), while secondary outcomes included the need for surgery. We reported descriptive statistics as percentages or median and interquartile range (IQR). We compared continuous data with the Mann-Whitney test and categorical data with Fisher's exact test; <i>P</i> < 0.05 was statistically significant.</p><p><strong>Results: </strong>Of the 59 studies, 20 case reports and 3 case series (n= 27 patients) met the inclusion criteria. There was no difference in mortality between cocaine-induced NOMI and non-cocaine NOMI (<i>P</i>=1.0). There were statistically significant differences between cocaine and non-cocaine vasoconstrictor-induced colonic NOMI regarding surgery (60% vs. 5.8%, <i>P</i>=0.03) and median LOS (7 days vs. 4 days, <i>P</i>=0.04).</p><p><strong>Conclusion: </strong>Cocaine-induced NOMI and non-cocaine NOMI both appear to have a relatively high but similar mortality rate, but the former is associated with increased requirement for surgery and LOS; prompt recognition of this clinical entity is required to improve outcomes.</p>","PeriodicalId":47429,"journal":{"name":"Clinical Medicine & Research","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2022-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544191/pdf/0200164.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10456210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complications Associated with Polydek Sutures Used in Eyelid Lateral Tarsal Strip Procedures. 眼睑外侧跗骨剥离手术中使用Polydek缝合线的并发症。
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-06-01 Epub Date: 2022-01-07 DOI: 10.3121/cmr.2021.1661
Lin Chen, Robert B Penne

Suture-related complications can occur in response to a patient's immune system activation regardless of surgical site. However, there is minimal literature describing complications related to commonly used Polydek sutures. We report the diagnosis, treatment, and follow up of four cases of Polydek suture-related complications post-eyelid lateral tarsal strip procedures, including an early wound healing problem/infection and later granuloma formation and/or suture extrusion that only resolved after removal of the Polydek suture or granuloma tissue. Use of non-Polydek sutures may reduce the likelihood for post-operative suture complications.

无论手术部位如何,缝合相关的并发症都可能发生在患者免疫系统激活的反应中。然而,很少有文献描述与常用Polydek缝合线相关的并发症。我们报告四例眼睑外侧跗骨剥离手术后Polydek缝线相关并发症的诊断、治疗和随访,包括早期伤口愈合问题/感染和后来的肉芽肿形成和/或缝线挤压,只有在去除Polydek缝线或肉芽肿组织后才能解决。使用非polydek缝合线可以减少术后缝合线并发症的可能性。
{"title":"Complications Associated with Polydek Sutures Used in Eyelid Lateral Tarsal Strip Procedures.","authors":"Lin Chen,&nbsp;Robert B Penne","doi":"10.3121/cmr.2021.1661","DOIUrl":"https://doi.org/10.3121/cmr.2021.1661","url":null,"abstract":"<p><p>Suture-related complications can occur in response to a patient's immune system activation regardless of surgical site. However, there is minimal literature describing complications related to commonly used Polydek sutures. We report the diagnosis, treatment, and follow up of four cases of Polydek suture-related complications post-eyelid lateral tarsal strip procedures, including an early wound healing problem/infection and later granuloma formation and/or suture extrusion that only resolved after removal of the Polydek suture or granuloma tissue. Use of non-Polydek sutures may reduce the likelihood for post-operative suture complications.</p>","PeriodicalId":47429,"journal":{"name":"Clinical Medicine & Research","volume":"20 2","pages":"107-110"},"PeriodicalIF":1.4,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242731/pdf/0200107.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39794904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Surveillance of Fluoroquinolone Resistance in Wisconsin: Geographic Variation and Impact of Revised CLSI Breakpoints. 威斯康星州氟喹诺酮类药物耐药性监测:地理差异和修订CLSI断点的影响
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-06-01 Epub Date: 2022-01-27 DOI: 10.3121/cmr.2021.1718
Giovanna Lazzerini, Stephen C Lavey, Barry C Fox, Erik Munson

Objective: Many clinical microbiology laboratories procure antimicrobial susceptibility testing data using guidelines established by Clinical and Laboratory Standards Institute (CLSI). When necessary, CLSI revises interpretive breakpoints in efforts to improve clinical correlation, with two revisions relative to fluoroquinolone agents occurring in 2019. The purpose of this investigation was to determine the impact of fluoroquinolone breakpoint revisions on Wisconsin clinical isolates of Escherichia coli, Proteus mirabilis, and Pseudomonas aeruginosa.Design: Multi-center laboratory surveillance, with testing at a single location utilizing standardized media and susceptibility testing protocols.Methods: From the Surveillance of Wisconsin Organisms for Trends in Antimicrobial Resistance and Epidemiology (SWOTARE) program, levofloxacin and ciprofloxacin minimum inhibitory concentration (MIC) values for 1911, 1521, and 1463 Wisconsin isolates of E. coli, P. mirabilis, and P. aeruginosa, respectively, were determined by broth microdilution testing. In separate data analyses, all MIC data were interpreted using CLSI breakpoints published prior to 2019, then secondarily by using CLSI breakpoints published since 2019 (which reflect lower breakpoints for both levofloxacin and ciprofloxacin resistance). Findings were further stratified by Wisconsin Department of Health Services region.Results: Up to 3.2% decreased statewide fluoroquinolone susceptibility was observed for E. coli isolates, while 5.1% and 6.3% decreases in levofloxacin susceptibility were noted for P. aeruginosa and P. mirabilis isolates, respectively, when revised breakpoints were applied. E. coli isolates from the Western region and P. mirabilis isolates from the Southeastern region demonstrated significant shifts toward decreased fluoroquinolone susceptibility upon application of revised breakpoints. Northern region P. mirabilis isolates exhibited consistently decreased fluoroquinolone susceptibility.Conclusions: Fluoroquinolone resistance has been underreported in Wisconsin as a whole, yet geographic variability continues to exist. Targeted annual surveillance is important to identify and monitor resistance trending. Compilations of SWOTARE surveillance data can be utilized to predict the impact of future CLSI interpretive breakpoint revisions in Wisconsin.

目的:许多临床微生物实验室使用临床与实验室标准协会(CLSI)制定的指南获取抗菌药物敏感性检测数据。必要时,CLSI修订了解释性断点,以提高临床相关性,2019年对氟喹诺酮类药物进行了两次修订。本研究的目的是确定氟喹诺酮类药物的断点修订对威斯康星州临床分离的大肠杆菌、奇迹变形杆菌和铜绿假单胞菌的影响。设计:多中心实验室监测,在单一地点使用标准化媒介和药敏试验方案进行检测。方法:采用微量肉汤稀释法测定1911、1521和1463株威斯康星州分离株大肠杆菌、P. mirabilis和P. aeruginosa的左氧氟沙星和环丙沙星最低抑菌浓度(MIC)。在单独的数据分析中,使用2019年之前公布的CLSI断点解释所有MIC数据,然后使用自2019年以来公布的CLSI断点(反映左氧氟沙星和环丙沙星耐药的较低断点)。研究结果进一步按威斯康星州卫生服务部地区分层。结果:在全州范围内,大肠杆菌分离株对氟喹诺酮类药物的敏感性降低了3.2%,而铜绿假单胞菌和奇异假单胞菌分离株对左氧氟沙星的敏感性分别降低了5.1%和6.3%。西部地区的大肠杆菌分离株和东南部地区的奇迹假单胞菌分离株在应用修订后的断点后显示出显著的变化,即氟喹诺酮类药物的敏感性降低。北部地区奇异假单胞菌分离株表现出持续降低的氟喹诺酮类药物敏感性。结论:氟喹诺酮类药物耐药性在威斯康星州整体上被低估,但地域差异仍然存在。有针对性的年度监测对于确定和监测耐药性趋势非常重要。SWOTARE监测数据的汇编可用于预测威斯康星州未来CLSI解释性断点修订的影响。
{"title":"Surveillance of Fluoroquinolone Resistance in Wisconsin: Geographic Variation and Impact of Revised CLSI Breakpoints.","authors":"Giovanna Lazzerini,&nbsp;Stephen C Lavey,&nbsp;Barry C Fox,&nbsp;Erik Munson","doi":"10.3121/cmr.2021.1718","DOIUrl":"https://doi.org/10.3121/cmr.2021.1718","url":null,"abstract":"<p><p><b>Objective:</b> Many clinical microbiology laboratories procure antimicrobial susceptibility testing data using guidelines established by Clinical and Laboratory Standards Institute (CLSI). When necessary, CLSI revises interpretive breakpoints in efforts to improve clinical correlation, with two revisions relative to fluoroquinolone agents occurring in 2019. The purpose of this investigation was to determine the impact of fluoroquinolone breakpoint revisions on Wisconsin clinical isolates of <i>Escherichia coli, Proteus mirabilis,</i> and <i>Pseudomonas aeruginosa.</i><b>Design:</b> Multi-center laboratory surveillance, with testing at a single location utilizing standardized media and susceptibility testing protocols.<b>Methods:</b> From the Surveillance of Wisconsin Organisms for Trends in Antimicrobial Resistance and Epidemiology (SWOTARE) program, levofloxacin and ciprofloxacin minimum inhibitory concentration (MIC) values for 1911, 1521, and 1463 Wisconsin isolates of <i>E. coli, P. mirabilis,</i> and <i>P. aeruginosa,</i> respectively, were determined by broth microdilution testing. In separate data analyses, all MIC data were interpreted using CLSI breakpoints published prior to 2019, then secondarily by using CLSI breakpoints published since 2019 (which reflect lower breakpoints for both levofloxacin and ciprofloxacin resistance). Findings were further stratified by Wisconsin Department of Health Services region.<b>Results:</b> Up to 3.2% decreased statewide fluoroquinolone susceptibility was observed for <i>E. coli</i> isolates, while 5.1% and 6.3% decreases in levofloxacin susceptibility were noted for <i>P. aeruginosa</i> and <i>P. mirabilis</i> isolates, respectively, when revised breakpoints were applied. <i>E. coli</i> isolates from the Western region and <i>P. mirabilis</i> isolates from the Southeastern region demonstrated significant shifts toward decreased fluoroquinolone susceptibility upon application of revised breakpoints. Northern region <i>P. mirabilis</i> isolates exhibited consistently decreased fluoroquinolone susceptibility.<b>Conclusions:</b> Fluoroquinolone resistance has been underreported in Wisconsin as a whole, yet geographic variability continues to exist. Targeted annual surveillance is important to identify and monitor resistance trending. Compilations of SWOTARE surveillance data can be utilized to predict the impact of future CLSI interpretive breakpoint revisions in Wisconsin.</p>","PeriodicalId":47429,"journal":{"name":"Clinical Medicine & Research","volume":"20 2","pages":"81-88"},"PeriodicalIF":1.4,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242736/pdf/0200081.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39865034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Use of Opioid Analgesia after Surgery: Assessing Postoperative Prescriptions from a Patient and Surgeon Perspective. 术后阿片类镇痛药的使用:从患者和外科医生的角度评估术后处方。
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-06-01 Epub Date: 2022-01-27 DOI: 10.3121/cmr.2021.1630
Roshini J Ramwani, Jessica A Wernberg

Purpose: Nonmedical use of prescription opioids continues to be a public health crisis in the United States that disproportionately affects rural communities with diversion of pills from friends and family being the most common source. The primary goal of the study was to identify current opioid prescription practices, and to assess the discrepancy in amount of opioids prescribed by surgeons versus the amount needed post-operatively by patients. Patient factors that may influence postoperative analgesia needs and their management of leftover prescription opioids were also evaluatedMethods: Patients ≥18 years-of-age who underwent a surgery between July and December 2018 by the subspecialty departments of Acute Care and General Surgery at a tertiary care facility in the rural Midwest were surveyed at their first post-operative visit to assess their postoperative analgesic needs. Resident and attending surgeons in the above departments were also surveyed to identify different factors that influenced their narcotic prescription practices.Results: Surveys from 252 patients, 12 attending surgeons, and 14 general surgery residents met inclusion criteria. Of patients who received a narcotic prescription, 19.9% did not fill their prescription, 64.1% of whom were >60 years old, and 72.1% resided within an hour of the hospital. Average reported prescription size was 11-40 pills; however, most used more than 5 pills regardless of the type of operation (P=0.59) and history of chronic pain (P=0.07). Inability to call in narcotic prescriptions and patients' distance from care influenced providers' prescription practices, with 77.9% of resident physicians and 68.3% of attending surgeons stating they would prescribe fewer if given the ability to call in a narcotic prescription.Conclusions: Regardless of the operation complexity, a majority of patients required fewer than five opioid pills after discharge and would be willing to return leftover pills. Development of opioid stewardship programs within the healthcare sector may reduce the number of opioids available for diversion and misuse.

目的:处方类阿片的非医疗使用仍然是美国的一个公共卫生危机,对农村社区的影响不成比例,从朋友和家人那里转移药丸是最常见的来源。该研究的主要目的是确定当前的阿片类药物处方做法,并评估外科医生开出的阿片类药物数量与患者术后所需数量的差异。还评估了可能影响术后镇痛需求和剩余处方阿片类药物管理的患者因素。方法:在2018年7月至12月期间,在中西部农村三级医疗机构的急症护理和普通外科亚专科接受手术的患者≥18岁,在他们的第一次术后就诊时进行调查,以评估他们的术后镇痛需求。还对上述科室的住院医师和主治医师进行了调查,以确定影响其麻醉处方做法的不同因素。结果:252名患者、12名主治医生和14名普外科住院医师的调查符合纳入标准。在接受麻醉处方的患者中,19.9%的患者未按处方配药,64.1%的患者年龄>60岁,72.1%的患者居住在距医院1小时内。报告的平均处方大小为11-40片;然而,与手术类型(P=0.59)和慢性疼痛史(P=0.07)无关,大多数使用超过5粒。不能叫到麻醉品处方和患者与护理人员的距离影响了提供者的处方做法,77.9%的住院医生和68.3%的主治外科医生表示,如果能够叫到麻醉品处方,他们会减少处方。结论:无论手术复杂程度如何,大多数患者出院后所需阿片类药物少于5片,并愿意退还剩余的阿片类药物。在医疗保健部门制定阿片类药物管理方案可能会减少可用于转移和滥用的阿片类药物的数量。
{"title":"The Use of Opioid Analgesia after Surgery: Assessing Postoperative Prescriptions from a Patient and Surgeon Perspective.","authors":"Roshini J Ramwani,&nbsp;Jessica A Wernberg","doi":"10.3121/cmr.2021.1630","DOIUrl":"https://doi.org/10.3121/cmr.2021.1630","url":null,"abstract":"<p><p><b>Purpose:</b> Nonmedical use of prescription opioids continues to be a public health crisis in the United States that disproportionately affects rural communities with diversion of pills from friends and family being the most common source. The primary goal of the study was to identify current opioid prescription practices, and to assess the discrepancy in amount of opioids prescribed by surgeons versus the amount needed post-operatively by patients. Patient factors that may influence postoperative analgesia needs and their management of leftover prescription opioids were also evaluated<b>Methods:</b> Patients ≥18 years-of-age who underwent a surgery between July and December 2018 by the subspecialty departments of Acute Care and General Surgery at a tertiary care facility in the rural Midwest were surveyed at their first post-operative visit to assess their postoperative analgesic needs. Resident and attending surgeons in the above departments were also surveyed to identify different factors that influenced their narcotic prescription practices.<b>Results:</b> Surveys from 252 patients, 12 attending surgeons, and 14 general surgery residents met inclusion criteria. Of patients who received a narcotic prescription, 19.9% did not fill their prescription, 64.1% of whom were >60 years old, and 72.1% resided within an hour of the hospital. Average reported prescription size was 11-40 pills; however, most used more than 5 pills regardless of the type of operation (<i>P</i>=0.59) and history of chronic pain (<i>P</i>=0.07). Inability to call in narcotic prescriptions and patients' distance from care influenced providers' prescription practices, with 77.9% of resident physicians and 68.3% of attending surgeons stating they would prescribe fewer if given the ability to call in a narcotic prescription.<b>Conclusions:</b> Regardless of the operation complexity, a majority of patients required fewer than five opioid pills after discharge and would be willing to return leftover pills. Development of opioid stewardship programs within the healthcare sector may reduce the number of opioids available for diversion and misuse.</p>","PeriodicalId":47429,"journal":{"name":"Clinical Medicine & Research","volume":"20 2","pages":"89-94"},"PeriodicalIF":1.4,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242732/pdf/0200089.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39865036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ketorolac and Predicted Severe Acute Pancreatitis: A Randomized, Controlled Clinical Trial. 酮咯酸与预测严重急性胰腺炎:一项随机对照临床试验。
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-06-01 Epub Date: 2022-01-07 DOI: 10.3121/cmr.2021.1663
Zahra Vahdat Shariatpanahi, Shaahin Shahbazi, Erfan Shahbazi

Objective: We evaluated the effect of ketorolac on reducing the severity of acute pancreatitis.Design and Setting: Randomized clinical trial performed in a University hospital.Participants: There were 56 adult patients, with predicted severe acute pancreatitis, randomly divided into two groups.Methods: The patients in the study group received intravenous ketorolac, 10 mg, three times daily from the time of enrollment for a maximum of 5 days, as needed, along with standard medical treatment. Primary outcome measure was the change in the serum level of high sensitive C-reactive protein (hs-CRP). Patients were also followed up in terms of hospitalization duration, need for intensive care unit (ICU), organ failure development, persistent organ failure, pancreatic necrosis, nutritional assessment, and mortality. The study continued to gather clinical follow-up information up to 4 months.Results: Serum level of hs-CRP was significantly lower in the ketorolac group compared with the control group on days 3, 4, and 5. There were no significant differences in organ failure, pseudocyst formation, acute necrotic collection, mortality, and ICU transfer between groups. Days of hospitalization were significantly lower in the study group. The feeding start time was significantly shorter in the study group with no need for tube feeding in the ketorolac group. Frequency of NPO (not per oral) was significantly lower in the ketorolac group.Conclusion: The use of ketorolac may improve feeding outcomes and shorten length of hospitalization in predicted severe acute pancreatitis.

目的:评价酮咯酸对减轻急性胰腺炎严重程度的作用。设计和环境:在一所大学医院进行的随机临床试验。参与者:56例预测为严重急性胰腺炎的成年患者,随机分为两组。方法:研究组患者自入组时起,根据需要静脉注射酮罗拉酸,10 mg,每日3次,最长5天,同时给予标准药物治疗。主要观察指标为血清高敏c反应蛋白(hs-CRP)水平的变化。对患者的住院时间、重症监护病房(ICU)需求、器官衰竭发展、持续性器官衰竭、胰腺坏死、营养评估和死亡率进行随访。该研究持续收集临床随访信息长达4个月。结果:与对照组相比,酮咯酸组在第3、4、5天血清hs-CRP水平明显降低。两组间在器官衰竭、假性囊肿形成、急性坏死收集、死亡率和ICU转移方面无显著差异。研究组的住院天数明显较低。实验组开始喂食时间明显缩短,酮咯酸组不需要管饲。酮咯酸组NPO发生率(非每次口服)显著降低。结论:应用酮咯酸可改善重症急性胰腺炎患者的喂养效果,缩短住院时间。
{"title":"Ketorolac and Predicted Severe Acute Pancreatitis: A Randomized, Controlled Clinical Trial.","authors":"Zahra Vahdat Shariatpanahi,&nbsp;Shaahin Shahbazi,&nbsp;Erfan Shahbazi","doi":"10.3121/cmr.2021.1663","DOIUrl":"https://doi.org/10.3121/cmr.2021.1663","url":null,"abstract":"<p><p><b>Objective:</b> We evaluated the effect of ketorolac on reducing the severity of acute pancreatitis.<b>Design and Setting:</b> Randomized clinical trial performed in a University hospital.<b>Participants:</b> There were 56 adult patients, with predicted severe acute pancreatitis, randomly divided into two groups.<b>Methods:</b> The patients in the study group received intravenous ketorolac, 10 mg, three times daily from the time of enrollment for a maximum of 5 days, as needed, along with standard medical treatment. Primary outcome measure was the change in the serum level of high sensitive C-reactive protein (hs-CRP). Patients were also followed up in terms of hospitalization duration, need for intensive care unit (ICU), organ failure development, persistent organ failure, pancreatic necrosis, nutritional assessment, and mortality. The study continued to gather clinical follow-up information up to 4 months.<b>Results:</b> Serum level of hs-CRP was significantly lower in the ketorolac group compared with the control group on days 3, 4, and 5. There were no significant differences in organ failure, pseudocyst formation, acute necrotic collection, mortality, and ICU transfer between groups. Days of hospitalization were significantly lower in the study group. The feeding start time was significantly shorter in the study group with no need for tube feeding in the ketorolac group. Frequency of NPO (not per oral) was significantly lower in the ketorolac group.<b>Conclusion:</b> The use of ketorolac may improve feeding outcomes and shorten length of hospitalization in predicted severe acute pancreatitis.</p>","PeriodicalId":47429,"journal":{"name":"Clinical Medicine & Research","volume":"20 2","pages":"74-80"},"PeriodicalIF":1.4,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242735/pdf/0200074.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39796792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Medicine & Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1